| 書目名稱 | Cardiac Positron Emission Tomography |
| 副標題 | Viability, Perfusion |
| 編輯 | E. E. Wall,P. K. Blanksma,A. M. J. Paans |
| 視頻video | http://file.papertrans.cn/222/221810/221810.mp4 |
| 叢書名稱 | Developments in Cardiovascular Medicine |
| 圖書封面 |  |
| 描述 | Myocardial viability has become one of the most importantissues in clinical cardiology. In particular, absence or presence ofviability may be decisive in patient management, and the decision toperform angioplasty (PTCA) or bypass surgery (CABG) is frequentlybased on the accurate assessment of viability. Althoughechocardiography and conventional nuclear medicine techniques mayprovide valuable information on viability, positron emissiontomography (PET) is currently considered to be the gold standard forthe assessment of myocardial viability. The simultaneous evaluation ofmyocardial metabolism and perfusion allows precise delineation andaccurate quantification of residual myocardial viability in affectedregions. In addition, accurate quantification of myocardial perfusionalone may provide insight into the basic mechanisms of syndrome X andmay assist in the appropriate clarification of this clinicallycomplicated, but frequently occurring phenomenon. .Besides that, cardiac PET may deepen our insight into metabolism andperfusion of cardiac muscle disease, particularly in hypertrophiccardiomyopathy. Furthermore, receptor imaging studies with PET willbecome important as the study of cardia |
| 出版日期 | Book 1995 |
| 關(guān)鍵詞 | Bypass; PTCA; assessment; cardiovascular; cardiovascular system; echocardiography; heart |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-94-011-0023-6 |
| isbn_softcover | 978-94-010-4014-3 |
| isbn_ebook | 978-94-011-0023-6Series ISSN 0166-9842 |
| issn_series | 0166-9842 |
| copyright | Springer Science+Business Media Dordrecht 1995 |
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-10 03:47
發(fā)表于 2025-3-21 19:58:13
